Medical Communications

Bristol-Myers Squibb has announced that their immunotherapy drug, Opdivo (nivolumab), will be made available to patients in the UK through …

The pharmaceutical industry has a big problem and it’s one that keeps getting worse every year – how to stop …

NICE has approved Eisai’s Halaven (eribulin) for routine treatment of sufferers of locally advanced or metastatic breast cancer that has …

It has come to light that, over a 20 year period, Eli Lily has increased the price of its diabetes …

MSD, known as Merck in North America, has published results of a Phase I trial of verubecestat. The drug is …

The US Food and Drugs Administration (FDA) has issued a Chinese firm with a warning letter after claims it intentionally …

Gilead Sciences followed Pfizer in discreetly dropping a drug alongside its third quarter profit reports. The drug in question, for …

Multi Packaging Solutions (“MPS”)(NYSE: MPSX),  a global market leader in healthcare, spirits, confectionery and media packaging, has been voted the …

Takeda UK have appointed Marc Weeks to the newly created role of digital lead. The creation of the role comes as …

The awards ceremony, held at The Seven Dials Club, Covent Garden, London on Friday 7 October, drew leading event and …

Novartis has named Cynthia Chiaramitara as managing director of its plant in Grimsby, UK. She will take on the role …

Allergan will acquire Motus Therapeautics, a biopharmaceutical company that specialises in developing treatments for gastroparesis. It is another acquisition that …

Halloween is creeping up, and its business as usual for the pharma industry; the week has been full of shockers, …

BMS has announced its intention to restructure its operations alongside $3 billion share buyback and quarterly results which exceeded expectations.The …

The study, funded by the World Health Organization, found a jab was close to 96% effective in tests to ascertain …